U.S. Preventive Medicine Announces Investment Ba...( DALLAS and NEW YORK May 6 /- U.S....),Health

DALLAS and NEW YORK, May 6 /PRNewswire/ -- U.S. Preventive Medicine(R), (http://www.USPreventiveMedicine.com) the leader in prevention, today announced the company has selected its investment banking team, composed of Credit Suisse, Deutsche Bank, Merrill Lynch, UBS and Stanford Eagle to coordinate its long term capital strategy, mergers and acquisition efforts in the U.S. and internationally.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080506/NETU129LOGO )

"The selection of some of the nation's best investment banks to co-manage our long term capitalization and M&A strategy is significant as we continue to align this company with the 'best of the best' in the global financial markets. As the first entity in the U.S. and internationally to offer a full continuum of geographically dispersed, comprehensive solutions for personalized medicine including preventive care, wellness and disease management, the addition of these leading financial advisors is very important," said Christopher Fey, Chairman and CEO of U.S. Preventive Medicine. "This is just one more sequential step in our planned growth of the business."

Fey said U.S. Preventive Medicine's expansion into personalized medicine is the next step in the company's plan to provide practical solutions at every point in the healthcare continuum both nationally and internationally.

About U.S. Preventive Medicine:

U.S. Preventive Medicine(R), a privately owned company, is building the first personalized medicine business in the United States and internationally focused on prevention. The company offers employers, government agencies and consumers proprietary products that include The Prevention Plan(TM), a groundbreaking personalized wellness program delivered online to individuals; The Prevention Plan CM(TM), field-based chronic d
'/>"/>